- Cart - 0 item(s)
- $0.00
Your shopping cart is empty!
- Chemistry
- Bioactive Molecules
- Anti-infection
- Apoptosis
- Autophagy
- Cell Cycle/DNA Damage
- Cytoskeleton
- Epigenetics
- GPCR/G Protein
- Immunology/Inflammation
- JAK/STAT Signaling
- MAPK/ERK Pathway
- Membrane Transporter/Ion Channel
- Metabolic Enzyme/Protease
- Neuronal Signaling
- NF-κB
- PI3K/Akt/mTOR
- PROTAC
- Protein Tyrosine Kinase/RTK
- Stem Cell/Wnt
- TGF-beta/Smad
- Vitamin D Related/Nuclear Receptor
- Others
- Methylation
- Cytoskeletal Signaling
- Natural Products
- Alkaloids
- Amino acid
- Anthraquinones
- Cerebrosides
- Chalcones
- Coumarins
- Diterpenoids
- Flavonoids
- Iridoids
- Lignans
- Lipids
- Miscellaneous
- Monoterpenoids
- Other terpenes
- Phenols
- Phenylpropanoids
- Quinones
- Saccharides
- Sesquiterpenoids
- Steroids
- Tetraterpenoids
- Thiophenes
- Triterpenoids
- Xanthones
- Polyphenols
- Stibene glucosides
- Oligose
- Anthocyanins
- Miscellaneous
- Chromones
- Terpenoids
- Indoles
- Procyanidins
- Aliphatics
- Botanical Cyclopeptides
- ADCs
- Antibodies
- Multiplex IHC
- Material Science
- Others
[CAS NO. 1009816-48-1] ThiametG
| Ships within | Stock | Price | Qty | Total |
Please click "REQUEST A QUOTE" button if there is no stock, or you need other sizes or custom synthesis.
| Catalog: | HY-12588 |
| Brand: | MCE |
| CAS: | 1009816-48-1 |
Overview
| MDL | MFCD15144964 |
|---|---|
| Molecular Weight | 248.30 |
| Molecular Formula | C9H16N2O4S |
| SMILES | O[C@H]1[C@H](O)[C@@]2([H])N=C(NCC)S[C@@]2([H])O[C@@H]1CO |
16 Publications Citing Use of MCE
- [1]Nat Chem Biol. 2022 Jul 25.
- [2]Nat Commun. 2021 May 11;12(1):2672.
- [3]Redox Biol. 2021 Jul;43:101994.
- [4]EMBO Mol Med. 2021 Nov 29;e14678.
- [5]Leukemia. 2022 Jan 8.
- [6]Theranostics. 2020 Jun 1;10(16):7178-7192.
- [7]Cell Rep. 2021 Sep 21;36(12):109739.
- [8]Cell Rep. 2019 Aug 27;28(9):2386-2396.e5.
- [9]EMBO Rep. 2021 Apr 15;e51649.
- [10]Neurotherapeutics. 2021 Jan;18(1):340-363.
- [11]J Biomed Sci. 2022 Feb 14;29(1):13.
- [12]J Biol Chem. 2019 Nov 8;294(45):16620-16633.
- [13]Cell Signal. 2021 Apr 3;110002.
- [14]J Cancer Res Clin Oncol. 2022 Nov 18.
- [15]Burns Trauma. 08 October 2021.
- [16]In Vitro Cell Dev Biol Anim. 2022 May 5.
Summary
Thiamet G is a potent and selective inhibitor of O-GlcNAcase (OGA) , which acts to remove O-GlcNAc from modified proteins, with K i of 20 nM for human OGA.
IC50 & Target
Ki: 20 nM (Human OGA) [1]
In Vitro
Thiamet G (1 μM) induces a clear increase in the accumulation of O-GlcNAcylated proteins of ATDC5 cells. O-GlcNAc accumulation induced by Thiamet G also evokes a clear increase in the activity of these MMPs. Thiamet G (1 μM) induces the phosphorylation of JNK, ERK, and p38 but not phosphorylation of Akt [2] . Thiamet G (0.1-10 μM) does not significantly affect the cell viability. Thiamet G decreases phosphorylation of tau and alters the microtubule dynamics [3] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
In Vivo
Thiamet G (500 mg/kg/d) increases global and tau O-GlcNAc and reduces neurodegeneration. Thiamet G-treated group has 1.4-fold more motor neurons and hinders tau-driven neurodegeneration within this transgenic model. Thiamet G treatment therefore has no detectable effect on mice lacking the P301L transgene, indicating that prevention of neurodegeneration and weight loss is mediated by Thiamet G treatment only in the context of the P301L transgene. In Thiamet G-treated mice, the O-GlcNAc increases in the brain and spinal cord tissues [1] . Thiamet G (20 mg/kg, i.p.) increases O-GlcNAc levels in brain, liver, and knee of the C57BL/6 mice in a dose-dependent manner [2] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
Solvent & Solubility
H 2 O : ≥ 50 mg/mL ( 201.37 mM )
DMSO : ≥ 45 mg/mL ( 181.23 mM )
* "≥" means soluble, but saturation unknown.
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 4.0274 mL | 20.1369 mL | 40.2739 mL |
| 5 mM | 0.8055 mL | 4.0274 mL | 8.0548 mL |
| 10 mM | 0.4027 mL | 2.0137 mL | 4.0274 mL |
-
1.
Add each solvent one by one: PBS
Solubility: 50 mg/mL (201.37 mM); Clear solution; Need ultrasonic
-
2.
-
3.
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.08 mg/mL (8.38 mM); Clear solution
-
4.
Add each solvent one by one: 10% DMSO >> 90% corn oil
Solubility: ≥ 2.08 mg/mL (8.38 mM); Clear solution
References
- [1] Yuzwa SA, et al. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat Chem Biol. 2012 Feb 26;8(4):393-9.
- [2] Andrés-Bergós J, et al. The increase in O-linked N-acetylglucosamine protein modification stimulates chondrogenic differentiation both in vitro and in vivo. J Biol Chem. 2012 Sep 28;287(40):33615-28.
- [3] Ding N, et al. Thiamet-G-mediated inhibition of O-GlcNAcase sensitizes human leukemia cells to microtubule-stabilizing agent NSC 125973. Biochem Biophys Res Commun. 2014 Oct 24;453(3):392-7.
Arctom is a premier supply platform offering over 600K unique items of Building Blocks, Bioactive Molecules, Natural Products, ADC PEG Linkers, Antibodies, and other Research Chemicals for global pharmaceutical, biotech, university, and industrial customers. We accelerate your research by providing better and faster purchasing experience & services.